Lyra Therapeutics Cash Flow Statement (2021-2025) | LYRA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -7.80M-11.04M-11.05M-13.62M-11.91M-14.37M-14.77M-14.22M-16.25M-15.62M-15.65M-15.16M-22.45M-48.13M-11.87M-10.98M-8.55M-7.44M-5.98M
Depreciation and Depletion 0.07M0.30M0.40M0.28M0.28M0.30M0.30M0.26M0.28M-0.02M-0.07M0.11M0.14M0.20M0.02M0.18M0.13M0.20M0.10M
Share-based Compensation 0.60M0.66M0.73M0.78M0.84M1.11M1.74M1.76M1.61M1.35M1.44M1.48M2.16M1.12M1.49M1.94M0.82M0.91M0.03M
Gains from Sales and Divestitures 0.00M0.00M0.01M0.01M0.01M0.01M0.03M0.03M0.03M0.09M0.37M0.02M0.03M
Gains from Investment Securities 1.76M0.07M0.02M2.96M4.02M4.34M5.50M5.87M5.84M5.71M8.05M7.05M-13.57M4.51M0.09M0.07M
Asset Writedowns and Impairment 1.59M0.01M1.88M0.02M
Cash from Restructuring 1.73M-0.51M-0.31M-0.55M-0.43M
Non-cash Items 0.67M0.72M7.50M0.92M0.77M1.12M1.25M0.38M0.06M3.09M2.65M6.33M12.87M1.40M1.30M2.82M
Cash from Operations -7.59M3.38M-10.31M-11.30M-11.90M-8.47M-10.85M-12.16M-15.85M-14.28M-14.11M-19.06M-22.45M-19.98M-16.22M-11.35M-8.84M-6.59M-7.36M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.73M0.63M1.06M1.09M0.93M0.68M0.40M0.27M
Depreciation & Amortization (CF) 0.07M0.30M0.40M0.28M0.28M0.30M0.30M0.26M0.28M-0.02M-0.07M0.11M0.14M0.20M0.02M0.18M0.13M0.20M0.10M
Change in Working Capital
Change in Account Payables 0.45M0.29M0.42M1.18M-0.66M-0.98M1.47M-2.24M3.29M-0.11M0.80M-3.54M-0.56M2.38M-2.59M-1.11M-0.45M-0.04M-0.12M
Change in Accured Expenses -0.98M0.96M0.99M0.28M-0.09M1.29M1.61M1.96M-2.32M-0.61M2.30M2.12M0.83M-3.33M-2.90M-0.57M-0.34M-0.20M-0.94M
Investing Activities
Capital Expenditures 1.16M0.62M0.52M1.08M0.09M0.01M0.03M0.03M0.04M0.07M0.14M0.79M2.15M0.20M0.05M-0.06M0.05M
Change in Acquisitions & Divestments 9.80M25.00M28.00M48.09M30.53M50.99M21.00M28.07M
Cash from Investing Activities -1.16M-0.62M-0.52M-1.08M-0.09M-0.01M-0.03M-64.87M5.32M-0.56M-14.98M-2.36M7.86M36.18M8.14M28.13M
Financing Activities
Other financing activities 0.10M0.00M0.00M4.01M0.24M0.42M0.32M0.17M0.10M0.02M0.37M
Change in Capital Stock
Shares Issued 0.26M0.33M0.01M0.01M0.00M0.10M0.00M0.00M
Misc.
Cash from Financing Activities 0.26M0.18M-0.08M-0.00M0.01M96.49M-0.24M0.00M47.19M-0.42M18.92M8.64M-0.09M-0.02M-0.00M-0.37M
Change in Cash -8.49M2.94M-10.91M-12.38M-11.99M88.00M-11.11M-77.03M-10.53M32.34M-29.51M-2.50M-5.95M16.11M-8.11M16.78M-8.84M-1.95M-7.73M
Free Cash Flow -8.75M2.76M-10.83M-12.38M-12.00M-8.48M-10.88M-12.19M-15.89M-14.35M-14.26M-19.84M-24.60M-20.18M-16.27M-11.29M-8.84M-6.59M-7.41M
Net Cash Flow -8.49M2.94M-10.91M-12.38M-11.99M88.00M-11.11M-77.03M-10.53M32.34M-29.51M-2.50M-5.95M16.11M-8.11M16.78M-8.84M-6.59M-7.73M